Exact Sciences (EXAS) Equity Average (2011 - 2025)

Exact Sciences (EXAS) has 15 years of Equity Average data on file, last reported at $2.5 billion in Q4 2025.

• Equity Average for Q4 2025 came in at $2.5 billion, down 12.65% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.5 billion (down 12.65% YoY), and the FY2025 annual result was $2.4 billion, down 13.42% from the prior year.
• Equity Average declined to $2.5 billion in Q4 2025 per EXAS's latest filing, from $2.5 billion in the prior quarter.
• Over five years, Equity Average peaked at $3.6 billion in Q2 2021 and troughed at $2.4 billion in Q1 2025.
• A 5-year average of $3.0 billion and a median of $3.1 billion in 2023 frame the typical range for Equity Average.
• The sharpest annual moves came in 2021 and 2025: Equity Average surged 93.93% in 2021, then declined 23.56% in 2025.
• A 5-year view of Equity Average shows it stood at $3.4 billion in 2021, then dropped by 10.13% to $3.1 billion in 2022, then grew by 1.87% to $3.1 billion in 2023, then dropped by 10.43% to $2.8 billion in 2024, then dropped by 12.65% to $2.5 billion in 2025.
• Business Quant data shows EXAS's Equity Average at $2.5 billion in Q4 2025, $2.5 billion in Q3 2025, and $2.4 billion in Q2 2025.